Keyphrases
Escherichia Coli
100%
Urinary Tract Infection
100%
Uropathogenic Escherichia Coli
100%
Renal Abscess
100%
Intratubular
100%
Androgen Exposure
100%
Abscess
33%
Androgens
33%
Toll-like
16%
Mouse Model
16%
Leukocytes
16%
Novel Therapeutics
16%
Fibrosis
16%
Male Sex
16%
Abscess Formation
16%
Patient Demographics
16%
Recurrent Urinary Tract Infections (rUTIs)
16%
Male Mice
16%
Biofilm
16%
Post-infection
16%
Female Mice
16%
Androgen Signaling
16%
Pyelonephritis
16%
Therapeutic Routes
16%
Androgen Receptor
16%
Dihydrotestosterone
16%
Androgen Receptor Antagonist
16%
Tubular Epithelium
16%
Enzalutamide
16%
Male Population
16%
Preclinical Modeling
16%
Upper Tract
16%
Female Host
16%
Medicine and Dentistry
Urinary Tract Infection
100%
Androgen
100%
Kidney Abscess
100%
Escherichia coli
100%
Uropathogenic Escherichia Coli
85%
Abscess
42%
Androgen Receptor
28%
Infection
14%
Leukocyte
14%
Fibrosis
14%
Lifespan
14%
Patient Population
14%
Toll Like Receptor 4
14%
Pyelonephritis
14%
Androstanolone
14%
Androgen Receptor Antagonist
14%
Enzalutamide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Escherichia coli
100%
Urinary Tract Infection
100%
Kidney Abscess
100%
Androgen
100%
Uropathogenic Escherichia Coli
85%
Abscess
42%
Androgen Receptor
28%
Infection
14%
Mouse Model
14%
Fibrosis
14%
Toll Like Receptor 4
14%
Androgen Receptor Antagonist
14%
Androstanolone
14%
Enzalutamide
14%
Pyelonephritis
14%
Immunology and Microbiology
Escherichia coli
100%
Urinary Tract
100%
Abscess
100%
Uropathogenic Escherichia Coli
85%
Mouse Model
14%
Leukocyte
14%
Lifespan
14%
Biofilm
14%
TLR4
14%
Pyelonephritis
14%
Veterinary Science and Veterinary Medicine
Urinary Tract Infection
100%
Pyelonephritis
14%